Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06890312
NA

Timing of Anticoagulant Administration During Radial Access Percutaneous Coronary Intervention: the HERA-PCI Study (Heparin Early for Radial Access Percutaneous Coronary Intervention)

Sponsor: University Hospital, Strasbourg, France

View on ClinicalTrials.gov

Summary

While the reduced hemorrhagic risk of radial access for percutaneous coronary intervention compared to femoral access is well-established, its main complication remains radial artery occlusion, which can occur in up to 30% of patients. Anticoagulation is the primary preventive measure recommended in clinical practice to reduce the risk of this complication, typically involving heparin injection during the procedure in most centers. However, data on the effect of the timing of heparin injection are limited. The investigators hypothesize that injection of heparin before sheath insertion may reduce the rate of radial artery occlusion compared with injection after sheath insertion.

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

550

Start Date

2025-06-05

Completion Date

2026-01

Last Updated

2025-09-05

Healthy Volunteers

No

Interventions

PROCEDURE

Administration of heparin after sheath insertion

Administration of heparin after sheath insertion

PROCEDURE

Administration of heparin prior to sheath insertion

Administration of heparin prior to sheath insertion

Locations (1)

Hôpitaux Universitaires de Strasbourg

Strasbourg, Bas-Rhin, France